About Clear Genetics
Clear Genetics is a Healthcare company based in San Francisco (United States) founded in 2016, and was acquired by Invitae in November 2019. Chatbot and telemedicine platform for genetic results interpretation is provided. It operates in the Healthcare and Technology sectors. Clear Genetics has raised $120 thousand across 2 funding rounds from investors including Invitae, Alchemist Accelerator and Y Combinator. Clear Genetics offers products and services including Gia Chatbot and Genetic Testing Platform. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Telemedicine. Its competitors include Helix, Benchling and Syllable; 3 of its 3 listed competitors have raised funding.
Company details
Clear Genetics was founded in 2016 in San Francisco, United States. A chatbot and telemedicine platform is operated in the genetics health sector to interpret results. Users are guided through genetic findings via conversational interface, information is collected, and testing options are reviewed. Insurance coverage inquiries are addressed. Video or in-person consultations with experts are scheduled as needed.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Website cleargenetics.com
- Social LinkedIn X
- Acquired by Invitae (Nov 2019)
Products & Services of Clear Genetics
Clear Genetics offers a comprehensive portfolio of products and services, including Gia Chatbot and Genetic Testing Platform.
Facilitates genetic testing intake, education, and results delivery for patients.
Platform for ordering and managing genetic tests via automated processes.
Funding Insights of Clear Genetics
Clear Genetics has successfully raised a total of $120K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $120,000
- Total Rounds 2
- First Round $120,000
(Mar 2017)
- Investors Count 2
All 2 funding rounds of Clear Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | Seed | – | Alchemist Accelerator | – | |
| Mar 2017 | $120,000 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Clear Genetics
Clear Genetics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Invitae, Alchemist Accelerator and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Enterprise startups are accelerated via a 6-month program. | alchemistaccelerator.com | San Francisco, United States | ||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Home-based genetic tests for detecting diseases are provided to individuals. | 2010 | invitae.com | San Francisco, United States |
Investor details for Clear Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Clear Genetics
716 people are tracked at Clear Genetics (295 in leadership, 9 in board & advisors, 412 in team).
| Name | Role | Group |
|---|---|---|
Adam H. Schechter | President & CEO | Leadership |
Charles Houck | Director Of Information Technology For Covance Market Access Services | Leadership |
Sandra D. Van Der Vaart | EVP, Chief Legal Officer, Chief Compliance Officer, & Corporate Secretary | Leadership |
John Ratliff | CEO, LabCorp Diagnostics | Leadership |
Kent Pearson | Director, IT Enterprise Monitoring And Operations | Leadership |
Crystal Icenhour | Microbiome & Specialty Infectious Disease Director | Leadership |
Bobbi Croy | Vice President IT | Leadership |
Libby Williams | Director - IT Infrastructure, Integration Services | Leadership |
Joseph Campo | Associate Vice President / IT Director - Client Connectivity & Support | Leadership |
Crystal Lala | Pre-clinical Med-device Director Of Operations | Leadership |
Nezabravka Tzvetanova | Business Development Director | Leadership |
Jordan Woodrick | Director Of Operations | Leadership |
Lucas Rifkin | Senior Medical Director | Leadership |
Kim Dugan | Director Specialty Analytics And Support | Leadership |
Will Stimpson | Global Executive Director Business Development - CMC | Leadership |
Julia Wang | EVP & CFO | Leadership |
Howard D. Engler | Associate Vice President | Leadership |
Amanda Kukulski | Senior Director, Data Products | Leadership |
Jim Maruca | Senior Vice President | Leadership |
Rachel McInerney | Vice President Of Human Resources | Leadership |
696 more people are available in the full profile.
Complete people profiles for Clear Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Clear Genetics
4 dated milestones of Clear Genetics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Clear Genetics is founded.
- Funding First funding round of $120K.
- Funding Latest funding round, Seed,.
- Exit Acquired by Invitae.
Competitors of Clear Genetics
Clear Genetics has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and Syllable.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| syllable.ai | 2016 | San Francisco, United States | $85.6M | 46 | AI-based digital assistants for healthcare communication are provided. |
Detailed competitors of Clear Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Clear Genetics (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clear Genetics
Complete news archive for Clear Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clear Genetics
Clear Genetics was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Clear Genetics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Clear Genetics is a funded company, having raised a total of $120K across 2 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Mar 2017.
Clear Genetics was founded in 2016 in San Francisco, United States. A chatbot and telemedicine platform is operated in the genetics health sector to interpret results. Users are guided through genetic findings via conversational interface, information is collected, and testing options are reviewed. Insurance coverage inquiries are addressed. Video or in-person consultations with experts are scheduled as needed.
Clear Genetics offers Gia Chatbot and Genetic Testing Platform.
Clear Genetics has 3 investors. Key investors include Invitae, Alchemist Accelerator, and Y Combinator.
Yes. Clear Genetics was acquired by Invitae in November 2019.